Caricamento...
Preclinical development of CD126 CAR-T cells with broad antitumor activity
Chimeric antigen receptor T (CAR-T) cell therapy is a transformative approach to cancer eradication. CAR-T is expensive partly due to the restricted use of each CAR construct for specific tumors. Thus, a CAR construct with broad antitumor activity can be advantageous. We identified that CD126 is exp...
Salvato in:
| Pubblicato in: | Blood Cancer J |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7791061/ https://ncbi.nlm.nih.gov/pubmed/33414408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-00405-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|